|
Volumn 370, Issue 25, 2014, Pages 2362-2365
|
Tuberculosis control in New York City - A changing landscape
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BEDAQUILINE;
ISONIAZID;
RIFAPENTINE;
CHEMOTHERAPY;
DIABETES MELLITUS;
DIRECTLY OBSERVED THERAPY;
DISEASE ASSOCIATION;
DISEASE COURSE;
DRUG COST;
DRUG SENSITIVITY;
GENE SEQUENCE;
HIGH RISK POPULATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNOSUPPRESSIVE TREATMENT;
INCIDENCE;
MULTIDRUG RESISTANT TUBERCULOSIS;
NONHUMAN;
PREDICTIVE VALUE;
PREVALENCE;
PRIORITY JOURNAL;
PUBLIC HEALTH SERVICE;
RISK FACTOR;
SHORT SURVEY;
SOCIAL MEDIA;
TUBERCULIN TEST;
TUBERCULOSIS;
UNITED STATES;
URBAN AREA;
COMMUNICABLE DISEASE CONTROL;
DISEASE TRANSMISSION, INFECTIOUS;
EMIGRANTS AND IMMIGRANTS;
FINANCING, GOVERNMENT;
HUMANS;
NEW YORK CITY;
RISK FACTORS;
TUBERCULOSIS;
TUBERCULOSIS, MULTIDRUG-RESISTANT;
UNITED STATES;
|
EID: 84902602776
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMp1402147 Document Type: Article |
Times cited : (14)
|
References (5)
|